Dr. Codrin Lungu is a Program Director in the Division of Clinical Research. He has a background and expertise in Movement Disorders, with particular interests in Parkinson disease, dystonia, deep brain stimulation therapy and neurotoxins. Most recently, Dr. Lungu has been the Chief of the NIH Parkinson clinic, which he has led for over 5 years. He has also established, in collaboration with the Surgical Neurology Branch, the first NIH Deep Brain Stimulation program, and has led the NIH Botulinum Toxin clinic for 8 years. His experience includes research in imaging biomarkers, neuromodulation, and early clinical trials of novel therapeutic agents. He has been co-directing the NIH Movement Disorders fellowship and remains involved in education and promotion of research.
Dr. Lungu earned his MD in Romania; performed neuroscience research at the University of Rochester; completed his Neurology Residency in the North Shore –LIJ campus of Albert Einstein College of Medicine; and completed fellowships in Movement Disorders at Harvard Medical School (Beth Israel Deaconess Medical Center) and NIH (Human Motor Control Section).
His current interests include research and trials in movement disorders, including Parkinson's disease, dystonia, tremor, myoclonus; clinical applications of neuromodulation, particularly deep brain stimulation; clinical applications of therapeutic neurotoxins; studies of novel therapies in neurodegenerative disorders, movement disorders and other neurologic conditions.